Literature DB >> 20346322

Screening stress myocardial perfusion imaging and eligibility for liver transplantation.

Steven M Bradley1, Laurie A Soine, James H Caldwell, Steven L Goldberg.   

Abstract

Screening for coronary artery disease is common practice in the evaluation of liver transplantation candidates. However, it is unclear whether coronary screening influences transplantation eligibility. We sought to determine the association between screening stress myocardial perfusion imaging (MPI) results and the eligibility for liver transplantation. Within a retrospective cohort of liver transplantation candidates referred for screening stress MPI at a single institution from April 1998 to February 2004, we obtained the baseline characteristics, stress MPI results, transplantation eligibility, and transplantation denial criteria by chart review. Of 294 patients (39%) denied transplantation, the denial criteria were multifactorial for 91 (31%) of the candidates. Compared to candidates with low-risk stress MPI results, the odds of being denied transplantation were the same for candidates with intermediate-risk MPI results (odds ratio 0.93, 95% confidence interval 0.45 to 1.82) or high-risk MPI results (odds ratio 1.42, 95% confidence interval 0.54 to 3.73). This lack of association persisted in our analysis with additional stratification of stress MPI results into negative, positive-low-risk, positive-intermediate-risk, and positive-high-risk. In conclusion, the screening stress MPI results were not associated with liver transplantation eligibility. The large number of competing factors considered before transplantation listing and the low proportion of positive stress MPI results suggests that targeting screening to patients deemed otherwise acceptable for transplantation might increase the influence of stress MPI findings on transplantation eligibility. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20346322     DOI: 10.1016/j.amjcard.2009.11.023

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  13 in total

Review 1.  Perioperative Cardiovascular Evaluation for Orthotopic Liver Transplantation.

Authors:  Robert J Donovan; Calvin Choi; Asghar Ali; Douglas M Heuman; Michael Fuchs; Anthony A Bavry; Ion S Jovin
Journal:  Dig Dis Sci       Date:  2016-11-09       Impact factor: 3.199

Review 2.  Cardiac imaging for the assessment of patients being evaluated for kidney or liver transplantation.

Authors:  Kalindi Parikh; Andrew Appis; Rami Doukky
Journal:  J Nucl Cardiol       Date:  2014-10-08       Impact factor: 5.952

3.  Cardiac work-up protocol for liver transplant candidates: experience from a single liver transplant centre.

Authors:  Carrie Ye; Meghana Saincher; Puneeta Tandon; Glenda Meeberg; Randy Williams; Kelly W Burak; Vincent G Bain
Journal:  Can J Gastroenterol       Date:  2012-11       Impact factor: 3.522

4.  Safety of regadenoson in patients with end-stage liver disease.

Authors:  Wael Aljaroudi; Fahad Iqbal; Jayanth Koneru; Pradeep Bhambhvani; Jaekyeong Heo; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2010-09-18       Impact factor: 5.952

5.  SPECT myocardial perfusion imaging in liver transplantation candidates.

Authors:  W Lane Duvall; Aditi Singhvi; Nidhi Tripathi; Milena J Henzlova
Journal:  J Nucl Cardiol       Date:  2018-08-23       Impact factor: 5.952

6.  Progression to Cirrhosis Leads to Improvement in Atherogenic Milieu.

Authors:  Samarth Patel; Mohammad B Siddiqui; Anchalia Chandrakumaran; Viviana A Rodriguez; Masoud Faridnia; Jose Hernandez Roman; Emily Zhang; Michael V Patrone; Genta Kakiyama; Caroline Walker; Adam Sima; Robert J Minniti; Sherry Boyett; Jasmohan S Bajaj; Arun Sanyal; William M Pandak; Chandra Bhati; Mohammad Shadab Siddiqui
Journal:  Dig Dis Sci       Date:  2020-03-18       Impact factor: 3.199

Review 7.  Cardiac imaging for the assessment of patients being evaluated for liver transplantation.

Authors:  Kameel Kassab; Rami Doukky
Journal:  J Nucl Cardiol       Date:  2021-04-06       Impact factor: 3.872

8.  Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel.

Authors:  Maciej Banach; Manfredi Rizzo; Peter P Toth; Michel Farnier; Michael H Davidson; Khalid Al-Rasadi; Wilbert S Aronow; Vasilis Athyros; Dragan M Djuric; Marat V Ezhov; Robert S Greenfield; G Kees Hovingh; Karam Kostner; Corina Serban; Daniel Lighezan; Zlatko Fras; Patrick M Moriarty; Paul Muntner; Assen Goudev; Richard Ceska; Stephen J Nicholls; Marlena Broncel; Dragana Nikolic; Daniel Pella; Raman Puri; Jacek Rysz; Nathan D Wong; Laszlo Bajnok; Steven R Jones; Kausik K Ray; Dimitri P Mikhailidis
Journal:  Arch Med Sci       Date:  2015-03-14       Impact factor: 3.318

Review 9.  Recent advances in the diagnosis and management of cirrhosis-associated cardiomyopathy in liver transplant candidates: advanced echo imaging, cardiac biomarkers, and advanced heart failure therapies.

Authors:  Maryjane Farr; Paul Christian Schulze
Journal:  Clin Med Insights Cardiol       Date:  2015-01-28

10.  Preoperative cardiovascular investigations in liver transplant candidate: An update.

Authors:  Lalit Sehgal; Piyush Srivastava; Chandra Kant Pandey; Amit Jha
Journal:  Indian J Anaesth       Date:  2016-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.